News
-
-
-
PRESS RELEASE
Original-Research: Nabaltec AG (von NuWays AG): BUY
Analysis of Nabaltec AG by NuWays AG highlights challenges faced in Q1 with improvements anticipated for FY26. Preliminary figures show sales down 2.7% yoy but positive outlook for certain product segments. Target price of EUR 16.0 maintained -
-
-
-
-
-
-
PRESS RELEASE
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
Abivax announces repurchase of royalty certificates and pricing of $45M (€38.5M) offering of American Depositary Shares to strengthen balance sheet and enhance shareholder value